Product Name: Valilactone featured
Description: Valilactone is a fatty acid synthase inhibitor produced by a cultured strain of soil actinomycetes. Fatty acid synthase (FAS) is necessary for growth and survival of tumor cells and is a promising drug target for oncology.
CAS NO: 945714-67-0 Product: FPS-ZM1
Synonym: Valilactone; (-)-Valilactone.
IUPAC Chemical Name: 1-((2S,3R)-3-hexyl-4-oxooxetan-2-yl)heptan-2-yl formyl-L-valinate
In ChiKey: WWGVIIVMPMBQFV-HNNZKPGWSA-NBcr-Abl inhibitors
SMILE Code: CC(C)[C@@H](C(OC(C[C@@H]([C@H]1CCCCCC)OC1=O)CCCCC)=O)NC=O
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site：Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22151901
Chemical Formula：C22H39NO5
ExactMass: 397.2828
Molecular Weight: 397.556
Elemental Analysis: C, 66.47; H, 9.89; N, 3.52; O, 20.12
Related Posts
Product Name: Valilactone featured
Description: Valilactone is a fatty acid synthase inhibitor produced by a cultured strain of soil actinomycetes. Fatty acid synthase (FAS) is necessary for growth and survival of tumor cells and is a promising drug target for oncology.
CAS NO: 945714-67-0 Product: FPS-ZM1
Synonym: Valilactone; (-)-Valilactone.
IUPAC Chemical Name: 1-((2S,3R)-3-hexyl-4-oxooxetan-2-yl)heptan-2-yl formyl-L-valinate
In ChiKey: WWGVIIVMPMBQFV-HNNZKPGWSA-NBcr-Abl inhibitors
SMILE Code: CC(C)[C@@H](C(OC(C[C@@H]([C@H]1CCCCCC)OC1=O)CCCCC)=O)NC=O
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site：Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22151901
Chemical Formula：C22H39NO5
ExactMass: 397.2828
Molecular Weight: 397.556
Elemental Analysis: C, 66.47; H, 9.89; N, 3.52; O, 20.12
Related Posts
Product Name: Valilactone featured
Description: Valilactone is a fatty acid synthase inhibitor produced by a cultured strain of soil actinomycetes. Fatty acid synthase (FAS) is necessary for growth and survival of tumor cells and is a promising drug target for oncology.
CAS NO: 945714-67-0 Product: FPS-ZM1
Synonym: Valilactone; (-)-Valilactone.
IUPAC Chemical Name: 1-((2S,3R)-3-hexyl-4-oxooxetan-2-yl)heptan-2-yl formyl-L-valinate
In ChiKey: WWGVIIVMPMBQFV-HNNZKPGWSA-NBcr-Abl inhibitors
SMILE Code: CC(C)[C@@H](C(OC(C[C@@H]([C@H]1CCCCCC)OC1=O)CCCCC)=O)NC=O
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site：Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22151901
Chemical Formula：C22H39NO5
ExactMass: 397.2828
Molecular Weight: 397.556
Elemental Analysis: C, 66.47; H, 9.89; N, 3.52; O, 20.12